Exchanges

Vaccine Progress and What’s Next

10 min • 12 november 2020

Salveen Richter, lead analyst for the US Biotechnology sector in Goldman Sachs Research, talks about Pfizer’s clinical-trial results for its COVID-19 vaccine and the obstacles that still lie ahead for FDA approval and widespread distribution.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Senaste avsnitt

Podcastbild

00:00 -00:00
00:00 -00:00